Parenteral Drugs Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA-12NA
EBIT-29NA
Earning Per Share-40-25
Expenses2424
Net Profit-122-76
Net Profit Margin-995-891
Operating Profit Margin-96-174
Profit Before Tax-154-109
Dividends Per Share0NA
Operation Revenue129

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Parenteral Drugs is NA as of 2/24/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20172018201920202021
Operating Activities134167477112125
Investing Activities-1-19700
Financing Activities-134-167-574-112-125
Others00000
Net Cash Flow-0-000-0

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Parenteral Drugs is 125 as of 2/24/2024